Biocryst Pharmaceuticals Inc (BCRX)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value Activity % Port
1.
VenBio Select Advisor

Kurt Von Emster

12,570,000 $77,682,600 -4% 1.03%
2.
Kynam Capital

Derrick Tang

8,826,710 $54,549,068 +36% 4.2%
3.
Deerfield Management

James E. Flynn

8,135,804 $50,279,269 +63% 0.83%
4.
Alkeon Capital Management

Panayotis Takis Sparaggis

7,099,484 $43,874,811 +74% 0.07%
5.
Rock Springs Capital Management

Kris Jenner, Gordon Bussard, Graham Mcphail

3,619,258 $22,367,014 +4% 0.67%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$6.36 7,861 Director 44,951 2024-05-30 Filing
$6.40 2,500 Director 2,500 2024-05-24 Filing
$6.38 5,000 Director 86,818 2024-05-20 Filing
$6.25 15,000 Director 66,997 2024-05-20 Filing
$5.57 36,300 Officer 266,744 2024-05-14 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$6.32 8,600 Director 27,831 2024-06-24 Filing
$6.00 4,689 Director 27,742 2024-06-17 Filing
$6.11 6,698 Director 52,852 2024-06-14 Filing
$7.98 4,000 Director 25,611 2023-06-15 Filing
$8.04 12,866 Director 81,818 2023-06-14 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value % Port
1. 18,681,370 $111,901,408 0%
2. 17,763,720 $106,404,682 0%
3. 12,777,003 $76,534,248 0%
4. 4,260,638 $25,524,572 0%
5. 3,846,154 $23,038,463 15.49%
News See All